Amedica Corporation Announces Participation in Singular Research 9th Annual Best of the Uncovereds Conference
SALT LAKE CITY, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a commercial biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and sell novel medical devices, today announced its expected participation in the following investor conference:
Singular Research 9th Annual Best of the Uncovereds Conference
Monday, September 22, 2014
2:30 p.m. Pacific Time
Luxe Hotel in Los Angeles, CA
Eric Olson, CEO and President, will conduct a formal presentation and participate in one-on-one meetings.
Institutional investors that wish to request a meeting with Amedica Corporation should contact Singular Research.
About Amedica Corporation
Amedica is a company focused on the development and application of medical-grade silicon nitride ceramics. Amedica markets spinal fusion products and is developing a new generation of orthopaedic bearings for hip and knee arthroplasty. Amedica operates an ISO 13485 certified manufacturing facility and its spine products are FDA cleared, CE marked, and currently marketed in the U.S. and select markets in Europe and South America.
The Company's web site for news releases and other information is www.amedica.com.
CONTACT: Mike Houston
Director of Investor Relations
801-839-3534
mhouston@amedica.com
Released September 18, 2014